Successful long-term enzyme replacement therapy in a young adult with Fabry disease

被引：6
|
作者：
Kampmann, C. [1 ]
Kalkum, G. [1 ]
Beck, M. [1 ]
Whybra, C. [1 ]
机构：
[1] Univ Med Ctr Mainz, Ctr Dis Childhood & Adolescence, Sect Lysosomal Storage Dis & Cardiol, Mainz, Germany
来源：
CLINICAL GENETICS | 2013年 / 83卷 / 04期
关键词：
D O I：
10.1111/j.1399-0004.2012.01916.x
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
  • [41] Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic Fabry disease cardiomyopathy
    Frustaci, A.
    Verardo, R.
    Galea, N.
    Alfarano, M.
    Magnocavallo, M.
    Scialla, R.
    Sansone, L.
    Belli, M.
    Cristina, M.
    Frustaci, E.
    Russo, M. A.
    Chimenti, C.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [42] Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study
    Anderson, L. J.
    Wyatt, K. M.
    Henley, W.
    Nikolaou, V.
    Waldek, S.
    Hughes, D. A.
    Pastores, G. M.
    Logan, S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (06) : 969 - 978
  • [43] Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease
    Prabakaran, Thaneas
    Birn, Henrik
    Bibby, Bo M.
    Regeniter, Axel
    Sorensen, Soren S.
    Feldt-Rasmussen, Ulla
    Nielsen, Rikke
    Christensen, Erik I.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (03) : 619 - 625
  • [44] Long-Term Effects of Enzyme Replacement Therapy for Anderson-Fabry Disease Differences in Three Siblings with the Same Genotype
    Tsujiuchi, Mild
    Ebato, Mio
    Maezawa, Hideyuki
    Mizukami, Takuya
    Nogi, Ayaka
    Ikeda, Naoko
    Iso, Yoshitaka
    Suzuki, Hiroshi
    INTERNATIONAL HEART JOURNAL, 2019, 60 (01) : 208 - 214
  • [45] A PROTOCOL FOR THE SUCCESSFUL LONG-TERM ENZYME REPLACEMENT THERAPY OF SCURVY IN GUINEA-PIGS
    HADLEY, K
    SATO, P
    JOURNAL OF INHERITED METABOLIC DISEASE, 1988, 11 (04) : 387 - 396
  • [46] Long-term evolution of Fabry cardiomyopathy under enzyme replacement therapy in the Swiss Fabry cohort. An echocardiographic study
    Monney, P.
    Namdar, M.
    Schmied, C.
    Gruner, C.
    Dormond, O.
    Krayenbuhl, P. A.
    Barbey, F.
    Nowak, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 497 - 497
  • [47] TREATMENT OF GAUCHER DISEASE IN GREEK ADULT PATIENTS: LONG-TERM EXPERIENCE OF A COLLABORATIVE STUDY OF ENZYME REPLACEMENT THERAPY
    Repa, C.
    Marinakis, T. H.
    Tsaftaridis, P.
    Karkalousos, P.
    Komninaka, V.
    Athanassaki, K.
    Michelakakis, H.
    Anagnostopoulos, N. I.
    Symeonidis, A.
    CLINICAL THERAPEUTICS, 2009, 31 : S210 - S210
  • [48] Long-term effects of anti-proteinuric agents on Fabry associated renal disease in conjunction with enzyme replacement therapy.
    Tahir, H
    Alldredge, L
    Warnock, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A57 - A57
  • [49] Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study
    Madsen, Christoffer Valdorff
    Bundgaard, Henning
    Rasmussen, Ase Krogh
    Sorensen, Soren Schwartz
    Petersen, Jorgen Holm
    Kober, Lars
    Feldt-Rasmussen, Ulla
    Petri, Helle
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (04) : 207 - 216
  • [50] Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy
    Sergi, B.
    Conti, G.
    Paludetti, G.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2010, 30 (02) : 87 - 93
12345